Global Sufentanil Market, By Indication (Opioid Analgesic and Anaesthetic), Route of Administration (Intravenous Route, Epidural Route and Sublingual Route), Drug Type (Branded and Generic), Doses (Adult, Pediatrics and Geriatric), End Users (Hospitals, Clinics and Other), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Sufentanil Market
The sufentanil market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.10% in the above-mentioned research forecast period. The research, FDA approval and products under clinical trials of sufentanil are the factors for the growth of the sufentanil market.
For instance,
- In November 2018, the FDA has approved the AcelRx Pharmaceuticals, Inc. sublingual tablets (30mg) of sufentanil under the name of DSUVIA. The drug was used for the treatment of acute pain in the adults.
- The intranasal sufentanil is under clinical trial phase IV which will be used in the treatment of acute post-traumatic pain.
Sufentanil is an opioid analgesic which is also used as an anesthesia during surgery. The properties of the drug are shorter distribution and half-life and are more potent and effective then fentanyl. It is given through intravenous, epidural or sublingual route to the adult, paediatric and geriatric population. Approximately, 80% of the administered dose is excreted from the body within 24 hours and only 2% of the dose is eliminated as unchanged drug.
The rise in medical and gynaecological surgeries may enhance the market growth of sufentanil. In addition, the drug is also used with other drugs to increase the efficacy of the drug. For instance, in one of the case study report, the sufentanil was given along with ropivacaine for the epidural anesthesia and spinal-epidural anesthesia in labor analgesia. The results were concluded that it showed better analgesic activity, decrease the labor onset time and showed fewer side-effects and complications. The sufentanil drug is better than fentanyl analog because it shows higher therapeutic index and highly lipophilic as compared to fentanyl. These properties of sufentanil act as a driver for the sufentanil market growth. The limitation use for some patients or contradictions of these drugs may act as a restraint for the sufentanil market growth. For instance, sufentanil cannot be used for the patients with acute or severe bronchial asthma and patients having gastrointestinal issues. Sufentanil may cause the respiratory depression which may hamper the sufentanil market growth.
This sufentanil market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the sufentanil treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Sufentanil Market Scope and Market Size
The sufentanil market is segmented on the basis of indication, route of administration, drug type, doses, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of indication, the sufentanil market is segmented into opioid analgesic and anaesthetic.
- On the basis of route of administration, the sufentanil market is segmented into intravenous route, epidural route and sublingual route.
- On the basis of drug type, the sufentanil market is segmented into branded and generic.
- On the basis of doses, the sufentanil market is segmented into adult, pediatrics and geriatric.
- On the basis of end users, the sufentanil market is segmented to hospitals, clinics and other.
- On the basis of distribution channel, the sufentanil market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.
Global Sufentanil Market Country Level Analysis
Global sufentanil market is analysed and market size information is provided by country, indication, route of administration, drug type, doses, end users and distribution channel as referenced above.
The countries covered in the sufentanil market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share because it is easily available to healthcare, awareness among the physicians about advanced technological treatment and high healthcare expenditure from the companies and government. Asia-Pacific is considered as the second largest market due to the fastest growth of medical infrastructure, increased medical tourism and high population especially in China which leads to more awareness and usability of the drug.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The sufentanil market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to sufentanil market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the sufentanil market in the growth period.
Competitive Landscape and Sufentanil Market Share Analysis
The sufentanil market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sufentanil market.
The major players covered in the global sufentanil market report are Wuhan Fengzhulin, Janssen Pharmaceuticals, Cambrex, Mallinckrodt Pharmaceuticals, Hameln Rds, Kern Pharma, Cambrex, Cristalia, Akorn, Inc, Johnson Matthey among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-